Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local infiltration of liposomal bupivacaine around pancreatic incision and postoperative wound healing
ChiCTR2400094269Phase 4Recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine in Pancreatic neoplasia (3 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoints: Surgical wound assessment tool with scoring and Hollander wound evaluation score (HWES). Started Dec 2024; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
Pancreatic neoplasia
Beyond the preview
Go deeper on ChiCTR2400094269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400094269.